N umerous studies showed that impaired endotheliumdependent vasodilation and cardiac dysfunction in heart failure (HF) appear to be attributable to decreased endothelial NO synthesis and/or possibly to increased NO degradation by enhanced generation of superoxide (O 2 Ϫ ). Large deficiencies of endothelial NO synthase (eNOS) mRNA and protein as well as basal and stimulated NO production were observed in aortic endothelial cells 1 and cardiac microvessels 2 from conscious dogs with pacing-induced overt congestive heart failure (CHF). In the same animal model at the onset of cardiac decompensation, reduced basal cardiac NO production was associated with a fall of cardiac contractility and an elevated left ventricular end-diastolic pressure. 3 Similarly, impaired basal and stimulated NO productions, which were indirectly assessed by vascular cyclic GMP, were demonstrated in aortas 4 and pulmonary arteries 4, 5 from Wistar-Kyoto rats (WKY) with chronic HF after myocardial infarction (MI). In comparison, a normal acetylcholine-induced relaxation with reduction of basal NO release was found in small mesenteric arteries from this rat HF model. 6, 7 Conflicting data exist with regard to eNOS expression and activity in human beings with chronic HF. Increased cardiac expression of eNOS, however, with no increased eNOS activity, was found in end-stage human heart failure. 8 In contrast, a reduced eNOS expression 9 and decreased basal NO release 10 were observed in the coronary microcirculation in patients with HF. In comparison, basal forearm blood flow was preserved 11 or even increased. 12 Acetylcholine-induced dilation was attenuated in patients with chronic CHF, 11 and acetylcholine-induced nitrite production in isolated coronary microvessels from the human failing heart was depressed in comparison to control vessels. 13 There is evidence that endothelial dysfunction in CHF results from enhanced oxidative stress. Aortic rings from WKY subjected to MI showed endothelial dysfunction caused by an increased vascular O 2 Ϫ generation, which rapidly inactivates NO. 14 Also, increased basal O 2 Ϫ generation could be observed in myocyte homogenates from patients with CHF, 15 and increased reactive oxygen species, primarily O 2 Ϫ , were reported to occur in patients with CHF. 16 To date, NO bioavailability in chronic HF induced by MI was indirectly shown only, for example, by measurement of vasodilator response, vascular nitrite, or cyclic GMP production. Therefore, we directly investigated receptorindependent calcium ionophore (CaI)-stimulated NO release from aortic endothelial cells by using a porphyrinic microsensor placed in close proximity to the cell surface. Second, we simultaneously addressed CaI-stimulated O 2 Ϫ generation in aortic endothelial cells, which by the fast reaction with NO forms peroxynitrite (ONOO Ϫ ) and cytotoxic radicals, thereby possibly playing a role in endothelial and cardiac dysfunction induced by MI.
Methods

Animals and Surgical Procedures
The study was carried out with adult male WKY rats and spontaneously hypertensive rats (SHR) weighing 250 to 300 g (4 month old). For induction of HF by MI, the rats were anesthetized with a mixture of ketamine/xylazine (35/2 mg/kg IP). After intubation and ventilation, a left thoracotomy was performed under aseptic conditions through the third intercostal space. The pericardium was opened, the left coronary artery was ligated 2 mm distal to the aortic origin, and the chest was closed. Sham operation was identical but without coronary occlusion. All experiments were performed in accordance with the German animal protection law.
Final Measurements
Eight weeks after surgery, the animals were anesthetized again. Mean arterial blood pressure (MAP) and heart rate were measured through the right carotid artery. Thoracic aorta was taken for evaluation of endothelial function 17 and for determination of NO and O 2 Ϫ production. 18 After evaluation of cardiac functions (contractility, dP/dt max , and aortic flow index, AFI) in the working heart, 18 wet weights of total heart and left and right ventricles were determined.
Determination of Infarct Size
The left ventricle was transversely sectioned into 4 slices from the apex to the base. Infarct size was determined by planimetry and expressed as a percentage of total left ventricular mass. Animals with infarct sizes Ͻ20% and Ͼ40% were excluded from the study. Normotensive WKY had compensated HF, whereas SHR had decompensated HF with significantly enlarged left and right cardiac ventricular chambers and impaired ejection fraction. 19 Additionally, hydrothorax, subcutaneous edema, and lung edema (mg lung wet weight/100 g body weight, 559Ϯ48 for SHR and 441Ϯ87 for WKY) were observed.
Measurements of NO and O 2
؊
Detection of NO by a porphyrinic microsensor and its preparation were performed as previously described. 20, 21 The current, which is proportional to NO concentration, was measured by the porphyrinic sensor, which operated in amperometric mode. The sensor operated at a constant potential of 0.68 V versus saturated calomel electrode.
A microsensor capable of almost instantaneous indirect detection of O 2 Ϫ was prepared according to the general procedure described previously, 22 subsequently modified in our laboratory for single-cell measurements. 23 The superoxide sensor consists of 2 electrodes: electrode I for detection of the total concentration of H 2 O 2 generated stoichiometrically by the fast dismutation of O 2 Ϫ by superoxide dismutase and electrode II for the measurement of basal H 2 O 2 concentration. The difference between the currents generated by these 2 electrodes was used as the analytical signal for indirect O 2 Ϫ determination. Both microsensors operated at a potential of Ϫ0.26 V versus the saturated calomel electrode. The O 2 Ϫ sensor was combined with a NO sensor in one unit (tandem sensor) of total diameter of Ϸ4 to 5 m. Three separate instruments (EG&G PAR model 283, Potentiostat/Galvanostats) were used for the recording of NO and for O 2 Ϫ .
Measurement of Peroxynitrite
Dihydrorhodamine-123 was used to detect the production of ONOO Ϫ in aortic endothelial cells through oxidation to its fluorescent product (rhodamine), according to the procedure described previously. 24 
Statistical Analysis
The data are given as meanϮSEM. ANOVA was followed by multiple pairwise comparisons according to Tukey. Null hypotheses were rejected at a level of PϽ0.05. An expanded Methods section can be found in an online data supplement available at http://www.hypertensionaha.org.
Results
Blood Pressure and Heart Rate
The MAP was slightly reduced in infarcted WKY (72Ϯ2 versus sham 82Ϯ6 mm Hg) and significantly decreased in infarcted SHR (100Ϯ6 versus sham 124Ϯ8 mm Hg). Shamoperated SHR showed a significantly greater MAP when compared with sham-operated WKY rats (124Ϯ8 versus 82Ϯ6 mm Hg). The heart rate remained unaltered in infarcted WKY (351Ϯ14 versus sham 344Ϯ8 bpm) and was significantly enhanced in infarcted SHR (361Ϯ21 versus sham 316Ϯ8 bpm).
Working Heart
Contractility (dP/dt max ) was significantly decreased in infarcted WKY (2471Ϯ212 versus sham 3593Ϯ240 mm Hg/s) and in infarcted SHR (3674Ϯ312 versus sham 4860Ϯ164 mm Hg/s). In addition, contractility was significantly greater in shamoperated SHR (4863Ϯ161 mm Hg/s) when compared with sham-operated WKY (3597Ϯ246 mm Hg/s). AFI was measured by a transonic flow probe (Transsonic Systems Inc) connected to a flowmeter (Transsonic Systems) and related to left ventricular mass. AFI was slightly but not significantly reduced in infarcted WKY (16.4Ϯ2.7 versus sham 20.5Ϯ2.7 mL · min Ϫ1 · g heart wet weight
Ϫ1
) and significantly reduced in infarcted SHR (13.8Ϯ1.9 versus sham 23.3Ϯ1.3 mL · min Ϫ1 · g heart wet weight
).
Endothelial NO, O 2 ؊ , and ONOO
؊
The typical amperograms (current calibrated as a concentration versus time) showing CaI (A23187)-stimulated release of NO from aortic endothelial cells are depicted in Figure 1 , a and b. The rate of NO release was much faster for WKY (350Ϯ20 nmol/s) than for SHR (180Ϯ20 nmol/s). Chronic HF caused a decrease of the rates of NO release to similar levels (Ϸ60 nmol/s) for both rat strains. Maximally CaIstimulated NO release from aortic endothelial cells was significantly reduced by 47% (from 478Ϯ48 to 216Ϯ16 nmol/L) in WKY with compensated HF and by 47% (from 693Ϯ131 to 257Ϯ53 nmol/L) in SHR with CHF, when compared with respective sham-operated animals ( Figure 2a ). The amount of diffusible NO released by single endothelial cells in the period of 15 seconds after addition of CaI was similar (Ϸ70 amol) for both WKY and SHR. This amount decreased to Ϸ20 amol for both strains after chronic CHF (Figure 2b 
Endothelial Function
Endothelium-dependent relaxation in response to acetylcholine (0.1 mol/L) was significantly reduced in norepinephrine-precontracted (0.1 mol/L) aortic rings from infarcted animals when compared with the respective sham-operated groups (Figure 4) . Acetylcholine-induced aortic relaxation of sham-operated WKY was significantly less than in the respective aortas from SHR.
Discussion
This study shows that pronounced aortic endothelial and cardiac dysfunction in normotensive WKY with compensated HF, and especially SHR with CHF, are associated with decreased CaI-stimulated NO release from aortic endothelial cells. Concomitantly, increased CaI-stimulated O 2 Ϫ and ONOO Ϫ productions are observed in these cells. MI-induced reduction of bioactive NO reached similar levels in both rat strains, whereas the absolute increases in O 2 Ϫ and ONOO Ϫ production by MI are much higher in SHR. In our study, we also observed a slightly higher peak concentration of CaIstimulated NO release from aortic endothelial cells of shamoperated SHR than from aortic endothelial cells of the Ϫ , is an important mechanism for endothelial dysfunction in WKY with MI, and in particular for the severe CHF in infarcted SHR. However, in contrast to the peak concentrations of CaI-stimulated NO release from aortic endothelial cells, the amounts of NO produced over the time of 15 seconds by single endothelial cells were similar for both WKY and SHR. This indicates that a significant amount of NO produced by SHR is consumed by O 2 Ϫ . As the result of this reaction, the amount of diffusible, bioactive NO does not correlate with higher expression of eNOS in SHR. Although in our study sham-operated SHR showed a significantly higher (6-to 7-fold) endothelial O 2 Ϫ production than the respective aortic endothelium of WKY, endotheliumdependent aortic relaxation was slightly greater in SHR than in aortas from sham-operated WKY. A reduced local bioavailability of NO caused by inactivation of NO through O 2 Ϫ despite a normal or even enhanced NO synthesis has been shown in endothelial dysfunction, for example, associated with hypertension, 18 hypercholesterolemia, 27 and high-salt diet. 28 One reason for elevated endothelial O 2 Ϫ formation may be a dysfunctional activity of eNOS. It has been demonstrated that purified eNOS in the absence of its cofactor tetrahydrobiopterin (BH 4 ) 29, 30 or its substrate L-arginine 31 generates significant quantities of O 2 Ϫ rather than NO. Furthermore, exogenous addition of BH 4 to purified eNOS or 5-minute incubation of aortic rings from SHR with BH 4 results in a decreased/increased O 2 Ϫ /NO production. 26, 32 Several studies with cultured human endothelial cells, 33 canine coronary arteries, 34 or aortic rings from rats 35 indicate the capability of eNOS to produce O 2 Ϫ under certain pathological conditions. Dysfunctional eNOS also appears to be the main source of the CaI-stimulated O 2 Ϫ production in aorta of prehypertensive 36 and old 37 SHR. Other source(s) of the increased O 2 Ϫ formation may be vascular smooth muscle cells. 14 Furthermore, enhanced angiotensin II generation in HF 38 may also be responsible for enhanced vascular O 2 Ϫ formation through activation of a NAD(P)H-dependent oxidase in rat aortic smooth muscle cells. 39, 40 Our data indicate that in chronic HF and especially in CHF, increased production of endothelium-derived O 2 Ϫ and ONOO Ϫ appears to be a relevant mechanism for endothelial dysfunction by inactivating vasoprotective NO. 
